Lupin launches generic joint pain drug in US market

Lupin launches generic joint pain drug in US market

The company's product- Diclofenac Sodium Topical Solution 2 per cent- is the generic version of Horizon Pharma Therapeutics Pennsaid

PTIUpdated: Friday, December 09, 2022, 03:17 PM IST
article-image
Image credit: Wikipedia (Representative)

Lupin announced on Friday that it has launched a generic version of Pennsaid, which is used to treat knee pain caused by osteoarthritis, in the American market.

The company's product- Diclofenac Sodium Topical Solution 2 per cent- is the generic version of Horizon Pharma Therapeutics Pennsaid, Lupin said in a statement.

As per IQVIA MAT October 2022 data, Lupin said diclofenac sodium topical solution, 2 per cent, had estimated annual sales of USD 509 million in the US.

RECENT STORIES

Diwali 2025: Mumbai's MMR Sees Festive Trade Cross ₹70,000 Crore As India’s Sales Hit Record...

Diwali 2025: Mumbai's MMR Sees Festive Trade Cross ₹70,000 Crore As India’s Sales Hit Record...

India’s Diwali Sales Hit Record ₹6.05 Lakh Crore, Driven By Strong Consumer Demand: CAIT

India’s Diwali Sales Hit Record ₹6.05 Lakh Crore, Driven By Strong Consumer Demand: CAIT

Diwali 2025: Festive Season Ends With 24 Per Cent Surge In E-Commerce Orders; Quick Commerce Leads...

Diwali 2025: Festive Season Ends With 24 Per Cent Surge In E-Commerce Orders; Quick Commerce Leads...

Ola Electric Shares Fall After CEO Bhavish Aggarwal Named In Employee Suicide Case FIR

Ola Electric Shares Fall After CEO Bhavish Aggarwal Named In Employee Suicide Case FIR

Jindal Steel's Delegation To Visit Germany For Financial Evaluation Of Thyssenkrupp's Assets

Jindal Steel's Delegation To Visit Germany For Financial Evaluation Of Thyssenkrupp's Assets